Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Careium AB's revenue for the
three
months ended in Jun. 2026 was €22.92 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was €83.95 Mil.
Careium AB's Revenue per Share for the
three
months ended in Jun. 2026 was €0.94.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €3.45.
During the past 12 months, the average Revenue per Share Growth Rate of Careium AB was 9.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 11.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 7 years, Careium AB's highest 3-Year average Revenue per Share Growth Rate was 15.80% per year. The lowest was 5.60% per year. And the median was 13.85% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Careium AB Revenue Related Terms
Careium AB Revenue Historical Data
* Premium members only.
The historical data trend for Careium AB's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Security & Protection Services subindustry, Careium AB's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Careium AB Revenue vs Business Services Industry
For the Business Services industry and Industrials sector, Careium AB's Revenue distribution charts can be found below:
* The bar in red indicates where Careium AB's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €83.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careium AB (FRA:I81) has a Revenue of €83.95 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Careium AB and its competitors.
Is Careium AB's Revenue too high?
Careium AB's current Revenue is €83.95 Mil. Overall, Careium AB has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Careium AB's Revenue compare to ALLE and MSA?
Careium AB's Revenue of €83.95 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Business Services company?
A good Revenue depends on the Business Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Careium AB and its competitors. Careium AB's current Revenue is €83.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careium AB stock overvalued right now?
Based on GuruFocus' analysis, Careium AB (FRA:I81) is currently considered Fairly Valued. The stock's GF Value™ is €2.56, compared to a current price of €2.72 — trading 6.3% above its estimated fair value. The current Revenue is €83.95 Mil. Careium AB's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Careium AB (FRA:I81), the current Revenue is €83.95 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Careium AB (FRA:I81) Overvalued in 2026?
Based on GuruFocus' analysis, Careium AB stock appears to be overvalued.
The current stock price of €2.72 is trading 6.3% above its estimated GF Value™ of €2.56.
GuruFocus considers Careium AB to be Fairly Valued.
Key valuation signals for FRA:I81:
Revenue: €83.95 Mil
GF Value™: €2.56 vs. price of €2.72 (6.3% above fair value)
No single metric tells the full story. See the FRA:I81 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Careium AB is a player in technology-enabled care in Sweden which provides solutions to improve the safety, quality of life, and independence of seniors both inside and outside the home. It offers a complete digital alarm chain. Its product catalog includes security alarms, fall sensors, smoke detectors motion detectors, accessories such as cameras, electronic locks, robotic medication assistive devices, and secure communication with alarm response. Geographically it has a presence in Nordics, the United Kingdom and Ireland, Central Europe, and Other markets, Its majority of the revenue comes from Nordics.
85GF Score
Get the complete analysis for FRA:I81
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:I81 has been successfully added to your 
